LOADING
Comparing Johnson & Johnson (JNJ) and AbbVie Inc (ABBV), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $549.3B | -- |
| P/E Ratio | 26.5 | -- |
| Forward P/E | 19.3 | -- |
| PEG Ratio | 2.90 | -- |
| EPS | $8.62 | -- |
| Revenue Growth (YoY) | 9.9% | -- |
| Profit Margin | 21.8% | -- |
| Return on Equity | 26.4% | -- |
| Dividend Yield | 2.33% | -- |
| Beta | 0.26 | -- |
| 52-Week High | $250.24 | -- |
| 52-Week Low | $145.39 | -- |
| Volume | -- | -- |